INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹92 Cr | ₹361 Cr | ₹27 Cr | ₹125 Cr | ₹-19 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹361 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹125 Cr |
| Mar2021 | ₹-19 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | -74.63 | |
| Mar2024 | ₹361 Cr | 1,231.88 | |
| Mar2023 | ₹27 Cr | -78.25 | |
| Mar2022 | ₹125 Cr | Positive | |
| Mar2021 | ₹-19 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,952.8 Cr | -2.4% | 0.8% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -2.4% |
0.8% |
-25.5% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses